Advertisement

BNT162b2 COVID-19 Vaccination and Immune Response in Patients Undergoing Anticancer Treatment
Posted: 01/21/2022 | By: Kayci Reyer

Question 1 of 5

Among patients undergoing anticancer treatment, SARS–CoV-2 antibody response was strongest after a patient received how many doses of the BNT162b2 (BioNTech; Pfizer) vaccine?

Choose 1

A
1
B
2
C
3
D
No correlation was noted between number of doses received and strength of antibody response

CategoriesView All Quizzes

Tumor Type


Additional Topics



Conference Coverage